NCT06352970 Effects of Tuberculosis Infection on Development and Function of the Placenta
| NCT ID | NCT06352970 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lund University |
| Condition | Pregnancy Related |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2024-10-01 |
| Primary Completion | 2026-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2024-10-01 with a primary completion date of 2026-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to understand how tuberculosis (TB) infection impacts the function and development of the placenta, and whether TB infection can contribute to pregnancy-related disorders through effects on the placenta. The main questions it aims to answer are: * Does TB infection affect the structure of the placenta? * Does TB infection affect the function of the placenta? Pregnant women attending delivery clinics in Addis Abeba, Ethiopia, will be enrolled and classified for TB infection using a blood-based test. We will compare the following outcomes between women with TB infection and women without TB infection: * Pathological lesions of the placenta * Gene and protein expression patterns linked to pregnancy-related disorders * Infant outcome at birth and at 6 weeks after birth
Eligibility Criteria
Inclusion Criteria: * Women admitted for delivery to study sites * Written informed consent * Age 18 years or greater Exclusion Criteria: * Chronic comorbidities (other than TB, HIV or pregnancy-related disorder) * Twin pregnancy
Contact & Investigator
Per Bjorkman, MD, PhD
PRINCIPAL INVESTIGATOR
Lund University
Frequently Asked Questions
Who can join the NCT06352970 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Pregnancy Related. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06352970 currently recruiting?
Yes, NCT06352970 is actively recruiting participants. Contact the research team at per.bjorkman@med.lu.se for enrollment information.
Where is the NCT06352970 trial being conducted?
This trial is being conducted at Addis Ababa, Ethiopia.
Who is sponsoring the NCT06352970 clinical trial?
NCT06352970 is sponsored by Lund University. The principal investigator is Per Bjorkman, MD, PhD at Lund University. The trial plans to enroll 500 participants.